![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/30 | |
A61K 39/395 | |||
A61P 35/00 |
(11) | Number of the document | 3321286 |
(13) | Kind of document | T |
(96) | European patent application number | 17206703.5 |
Date of filing the European patent application | 2012-08-21 | |
(97) | Date of publication of the European application | 2018-05-16 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
11178370 | 2011-08-23 | EP | |
12168192 | 2012-05-16 | EP |
(72) |
AST, Oliver, CH
BRUENKER, Peter, CH
FAUTI, Tanja, CH
FREIMOSER-GRUNDSCHOBER, Anne, CH
NEUMANN, Christiane, CH
KLEIN, Christian, CH
MOESSNER, Ekkehard, CH
UMANA, Pablo, CH
|
(73) |
Roche Glycart AG,
Wagistrasse 10, 8952 Schlieren,
CH
|
(54) | BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES |
BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES |